Fetter Health Care Network-hollywood Site Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 5225 Highway 165, Hollywood, SC 29449 Phone: 843-889-2272 Fax: 843-889-2274 |
Fetter Health Care Network-hollywood Site Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 5225 Highway 165, Hollywood, SC 29449 Phone: 843-889-2272 Fax: 843-889-2274 |
Minnie Hughes Elementary School Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 8548 Willtown Rd, Hollywood, SC 29449 Phone: 843-723-9582 Fax: 843-723-7011 |
Baptist Hill Middle High School Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 5117 Baptist Hill Rd, Hollywood, SC 29449 Phone: 843-723-9582 Fax: 843-723-7011 |
Renovo Medical Consulting Internal Medicine Medicare: Medicare Enrolled Practice Location: 4770 Stono Links Dr, Hollywood, SC 29449 Phone: 615-714-6035 |
St Pauls Medical Group Clinic/Center Medicare: Medicare Enrolled Practice Location: 7610 Highway 164, Hollywood, SC 29449 Phone: 843-889-8018 Fax: 843-889-9133 |
Fetter Health Care Network -white Camp Mirgrant Location Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 7555 Sc Hwy 162, Hollywood, SC 29449 Phone: 843-722-4112 Fax: 843-577-8960 |
News Archive
Omnicell, Inc., a leading provider of medication management solutions to acute healthcare facilities, will display its latest innovations during the 45th American Society for Health-System Pharmacists Midyear Clinical Meeting and Exhibition from December 6-8 in Anaheim, California.
Kessler Foundation researchers have linked balance dysfunction in individuals with traumatic brain injury with diminished sensory acuity.
A genetic analysis of non-small cell lung cancer (NSCLC) patients on the phase III NRG Oncology RTOG 0617 clinical trial assessing radiation dose discovered that high dose radiation therapy is associated with shorter survival times among patients with a radiation-sensitive genotype in DNA repair pathway.
Initial studies of the proteins, CCSA-3 and CCSA-4, suggest they could be used to develop a blood test to identify at-risk individuals.
› Verified 4 days ago